"This analysis explores the critical shifts in the sector, highlighting a projected growth trajectory driven by technological integration and changing consumer dynamics."

According to analysts at Vantage Market Research, the Global Precision Biotics Market size is worth USD 5.18 Billion in 2025 and is projected to reach USD 12.94 Billion by 2035, growing at a CAGR (Compound Annual Growth Rate) of 9.6% from 2026 to 2035. Key trends include AI-assisted microbiome analytics, personalized nutrition programs, clinically validated microbial formulations, precision fermentation, microbiome sequencing, postbiotic ingredients, functional foods and beverages, digital health integration, and targeted solutions for metabolic, digestive, cognitive, immune, and women’s health applications.

Precision Biotics Market Overview

The global Precision Biotics Market is witnessing steady expansion as microbiome science becomes increasingly integrated into preventive healthcare, personalized nutrition, functional wellness, and medical nutrition. Precision biotics are designed to influence specific microbial pathways and physiological functions rather than providing generalized probiotic benefits. Advances in genomic sequencing, metabolomics, microbial pathway mapping, and computational biology are enabling manufacturers to develop more targeted and scientifically validated formulations.

Enterprise procurement increasingly emphasizes clinical evidence, manufacturing consistency, ingredient traceability, regulatory compliance, and formulation stability. Healthcare organizations, nutraceutical manufacturers, food companies, and research institutions are evaluating suppliers based on scientific documentation, proprietary microbial libraries, intellectual property strength, production scalability, and the ability to support customized formulations.

The expansion of functional foods, medical nutrition, dietary supplements, and personalized wellness programs is further broadening commercial opportunities. Precision biotics are increasingly being incorporated into nutritional products addressing digestive health, metabolic health, immune health, cognitive and mental wellness, women’s health, sports nutrition, and animal nutrition.

North America currently dominates the market, supported by established biotechnology ecosystems, microbiome research capabilities, premium nutrition spending, and personalized healthcare adoption. Asia Pacific is expanding through rising healthcare expenditure, biotechnology investment, nutrition awareness, and growing demand for functional foods and dietary supplements.

Overall, the Precision Biotics Market is positioned for continued commercial expansion as biotechnology companies, nutrition manufacturers, healthcare organizations, and diagnostic providers develop integrated microbiome solutions supported by scientific validation, advanced manufacturing, and digital health technologies.

Novonesis Expanded Precision Microbiome Research Platform to Accelerate Clinically Validated Nutritional Ingredient Development

March 2025 — Novonesis expanded its precision microbiome research platform to accelerate the development of clinically validated nutritional ingredients, supporting targeted microbiome applications across preventive healthcare and personalized nutrition.

Key Takeaways from the Report

Advancements in microbiome sequencing, genomic analysis, and computational biology are accelerating the development of targeted precision biotics.
Single-Strain Precision Biotics maintain a leading position due to established scientific evidence, targeted biological mechanisms, and streamlined clinical validation.
Cognitive & Mental Wellness represents a rapidly expanding application area as microbiome-gut-brain research supports new nutritional solutions.
Postbiotic Ingredients are gaining commercial traction because of formulation stability, shelf-life advantages, and broad application flexibility.
Functional Foods & Beverages are expanding as consumers increasingly seek microbiome-supporting products integrated into everyday dietary routines.
Online Channels are gaining importance through personalized nutrition platforms, subscription programs, microbiome testing services, and direct-to-consumer models.
North America remains the dominant regional market due to advanced biotechnology infrastructure, clinical research capabilities, and established nutrition industries.
AI-driven microbiome analytics, precision fermentation, automated microbial screening, and digital health integration are creating new opportunities across the precision biotics ecosystem.

Top Players

Novonesis A/S
Clasado BiosciencesOptiBiotix Health plc
ADM
Kerry Group plc
Hansen Holding A/S
Lallemand Inc.
Yakult Honsha Co., Ltd.
BioGaia AB
Probi AB
Winclove Probiotics
Morinaga Milk Industry Co., Ltd.

Report Coverage

Our market research reports provide comprehensive insights that are essential for strategic decision-making. We cover all key aspects of the market, including dynamics such as drivers, restraints, opportunities, and challenges, alongside the latest industry trends. Our analysis includes an in-depth technology roadmap, product life cycle evaluation, and PESTLE analysis, ensuring a thorough understanding of the market environment. We also assess GDP growth outlooks, examine regional market landscapes, and evaluate the impact of major events such as the COVID-19 pandemic. Additionally, our reports feature a detailed competitive landscape, including company market shares and profiles, providing actionable intelligence to empower your business strategies.

Latest Announcement

September 2025 — Clasado Biosciences enhanced its scientific validation program supporting next-generation precision prebiotic formulations, strengthening its research and development capabilities for targeted microbiome applications.

Meta Title

Meta Description

Meta Keywords